Radioimmunotherapy of prostate cancer: does tumor size matter?
- PMID: 15837975
- DOI: 10.1200/JCO.2005.01.903
Radioimmunotherapy of prostate cancer: does tumor size matter?
Comment on
-
Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer.J Clin Oncol. 2005 Jul 20;23(21):4591-601. doi: 10.1200/JCO.2005.05.160. Epub 2005 Apr 18. J Clin Oncol. 2005. PMID: 15837970 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
